Search research articles
Contact Us
Filters
Showing results (231-240 of 525) with videos related to
Page
of 53
Sort By:
Plos Pathogens
|
September 1, 2016
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
Matthew Zirui Tay, Pinghuang Liu, LaTonya D Williams, et al.
Vaccine Insights
|
April 24, 2023
The quest for vaccine-induced immune correlates of protection against tuberculosis
Elisa Nemes, Andrew Fiore-Gartland, Cesar Boggiano, et al.
Journal of Virology
|
August 26, 2011
Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection
Pinghuang Liu, R Glenn Overman, Nicole L Yates, et al.
The Journal of Infectious Diseases
|
January 8, 2019
Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period
Paul Spearman, Georgia D Tomaras, David C Montefiori, et al.
Vaccines
|
February 26, 2025
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
Xiaoying Shen, Bette Korber, Rachel L Spreng, et al.
Msphere
|
January 31, 2020
Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
Zanele Ditse, Nonhlanhla N Mkhize, Michael Yin, et al.
Cell
|
March 25, 2017
Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk
Gaddiel Galarza-Muñoz, Farren B S Briggs, Irina Evsyukova, et al.
Journal of Virology
|
June 26, 2009
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors
Elin S Gray, Natasha Taylor, Diane Wycuff, et al.
Plos One
|
July 24, 2014
HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities
Kelly E Seaton, Lamar Ballweber, Audrey Lan, et al.
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
Camille N Pierre, Lily E Adams, Kara Anasti, et al.
Page
of 53
Search research articles
Search
Showing results (231-240 of 525) with videos related to
Sort By:
Page
of 53
Plos Pathogens
|
September 1, 2016
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
Matthew Zirui Tay, Pinghuang Liu, LaTonya D Williams, et al.
Vaccine Insights
|
April 24, 2023
The quest for vaccine-induced immune correlates of protection against tuberculosis
Elisa Nemes, Andrew Fiore-Gartland, Cesar Boggiano, et al.
Journal of Virology
|
August 26, 2011
Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection
Pinghuang Liu, R Glenn Overman, Nicole L Yates, et al.
The Journal of Infectious Diseases
|
January 8, 2019
Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period
Paul Spearman, Georgia D Tomaras, David C Montefiori, et al.
Vaccines
|
February 26, 2025
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
Xiaoying Shen, Bette Korber, Rachel L Spreng, et al.
Msphere
|
January 31, 2020
Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
Zanele Ditse, Nonhlanhla N Mkhize, Michael Yin, et al.
Cell
|
March 25, 2017
Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk
Gaddiel Galarza-Muñoz, Farren B S Briggs, Irina Evsyukova, et al.
Journal of Virology
|
June 26, 2009
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors
Elin S Gray, Natasha Taylor, Diane Wycuff, et al.
Plos One
|
July 24, 2014
HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities
Kelly E Seaton, Lamar Ballweber, Audrey Lan, et al.
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
Camille N Pierre, Lily E Adams, Kara Anasti, et al.
Page
of 53